Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

34% of patients on hepatitis C treatment had reversible skin issues.

CD2 might be a new treatment target for patchy alopecia areata.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Astragaloside A may help fight lung cancer by targeting specific proteins.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

Some drugs may help treat both COVID-19 and radiation injury.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Provenge extends prostate cancer survival by about 4 months.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated for treating androgenetic alopecia.

CEC levels may be a useful marker for predicting prostate cancer progression.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.